Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Earnings Yield (Joel Greenblatt) % : -20.75% (As of Dec. 2014)

Omni Bio Pharmaceutical Earnings Yield (Joel Greenblatt) % Chart

Omni Bio Pharmaceutical Annual Data
	Trend	Dec06	Dec07	Dec08	Mar09	Mar10	Mar11	Mar12	Mar13	Mar14
Earnings Yield (Joel Greenblatt) %		Get a 7-Day Free Trial				-4.57	-9.50	-9.99	-62.50	-20.88

Omni Bio Pharmaceutical Quarterly Data
	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial															-31.06	-20.88	-30.77	-30.12	-20.75

Competitive Comparison of Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) %

For the Biotechnology subindustry, Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) % falls into.

Omni Bio Pharmaceutical Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Omni Bio Pharmaceuticals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2014 is calculated as

Omni Bio Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.42 Mil.

Omni Bio Pharmaceutical  (GREY:OMBP) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

Omni Bio Pharmaceutical Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description